These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11941025)

  • 21. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation.
    Mikkelsen JD; Woldbye DP
    J Psychiatr Res; 2006 Mar; 40(2):153-9. PubMed ID: 16459171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart.
    van den Brink OW; Delbridge LM; Rosenfeldt FL; Penny D; Esmore DS; Quick D; Kaye DM; Pepe S
    Heart Lung Circ; 2003; 12(3):178-87. PubMed ID: 16352129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.
    Fu CY; Yang Q; Wang KR; Kong ZQ; Chen Q; Wang R
    Behav Brain Res; 2006 Jun; 170(2):293-301. PubMed ID: 16621052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?
    Jackson HC; Weinberger PJ; Nutt DJ
    Convuls Ther; 1991; 7(1):20-27. PubMed ID: 11941092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
    Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
    Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.
    Ossipov MH; Lai J; King T; Vanderah TW; Porreca F
    Biopolymers; 2005; 80(2-3):319-24. PubMed ID: 15795927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous opiates and behavior: 2007.
    Bodnar RJ
    Peptides; 2008 Dec; 29(12):2292-375. PubMed ID: 18851999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes.
    Cycowicz YM; Luber B; Spellman T; Lisanby SH
    J ECT; 2009 Sep; 25(3):157-64. PubMed ID: 19300292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.
    Molina PE
    J Intern Med; 2006 Feb; 259(2):138-54. PubMed ID: 16420543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endogenous anticonvulsant and neuroprotective agents].
    Lasoń W
    Przegl Lek; 2004; 61(11):1263-7. PubMed ID: 15727028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.
    Zarrindast MR; Sahebgharani M; Burnham WM
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary opioid involvement in ECS-postictal electrogenesis and behavioral depression in rats.
    Tortella FC; Cowan A; Holaday JW
    Peptides; 1984; 5(1):115-8. PubMed ID: 6538682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
    Romero TR; de Castro Perez A; de Francischi JN; Gama Duarte ID
    Eur J Pharmacol; 2009 Apr; 608(1-3):23-7. PubMed ID: 19236861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice.
    Hebb AL; Drolet G; Mendella PD; Roach SP; Gauthier MS; Zacharko RM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):453-69. PubMed ID: 16290012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
    Guo Y; Wang HL; Xiang XH; Zhao Y
    Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous anticonvulsant substances.
    Dragunow M
    Neurosci Biobehav Rev; 1986; 10(3):229-44. PubMed ID: 3534653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of opioid-producing leukocytes for pain control.
    Machelska H
    Neuropeptides; 2007 Dec; 41(6):355-63. PubMed ID: 17640727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.